Proteostasis Therapeutics, Inc.
(NASDAQ : PTI)

( )
PTI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-1.05%87.301.3%$1275.26m
AMGNAmgen Inc.
-0.25%198.891.2%$667.61m
GILDGilead Sciences, Inc.
-1.28%67.640.9%$577.79m
BIIBBiogen Inc.
-1.63%332.031.3%$485.41m
LOXOLoxo Oncology Inc
-0.18%233.2612.7%$449.60m
ILMNIllumina, Inc.
0.05%305.633.5%$350.96m
VRTXVertex Pharmaceuticals Incorporated
-0.28%186.151.9%$318.23m
REGNRegeneron Pharmaceuticals, Inc.
-0.12%404.542.6%$308.69m
ALXNAlexion Pharmaceuticals, Inc.
-0.03%111.702.0%$229.47m
TSROTESARO, Inc.
0.03%74.8814.4%$201.67m
AAgilent Technologies, Inc.
-0.82%70.021.5%$164.25m
EXASExact Sciences Corporation
-2.75%74.9725.3%$151.07m
INCYIncyte Corporation
-2.79%76.562.5%$146.84m
SRPTSarepta Therapeutics, Inc.
0.45%119.2615.4%$142.24m
LGNDLigand Pharmaceuticals Incorporated
-16.48%110.0523.1%$105.44m

Company Profile

Proteostasis Therapeutics, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines intend to treat cystic fibrosis, protein conformational and neurodegenerative diseases. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA.